에이치엘사이언스

239610KOSDAQ기타 식품 제조업

48.5 / 100

Reference Date: 2026-04-13

Financial Score16.0 / 40

News Sentiment12.5 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 2.4% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

HCL Science is a technology platform company specializing in biotech healthcare innovations, offering services such as FDA-approved CDMO for API, R&D of natural drug candidates, inner beauty and pharmaceutical cosmetics, and microbiome projects. The company has expanded into DTC genetic analysis services and home beauty devices, leveraging its 45 registered patents and proprietary technologies to develop diverse products and services.

Number of Employees

91people

Average Salary

39.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 13.534.0Point

PBR

0.50Industry Average 0.644.0Point

In line with industry avg

ROE

-13.47Industry Average 2.720.0Point

Well below industry avg

Debt Ratio

0.24Industry Average 11.918.0Point

Half of industry avg (excellent)

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼18.2% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼61.1% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.6% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 7,630Won52-week high 12,72052-week low 7,080

1-month return4.0Point

1m +2.42% (slight rise)

Volume trend5.0Point

Volume flat

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-24
Neutral정기주주총회결과2026-03-24
Neutral사업보고서 (2025.12)2026-03-16
Neutral감사보고서제출2026-03-16